Welcome, Guest. Please login or register.
April 18, 2024, 03:17:03 am

Login with username, password and session length


Members
  • Total Members: 6307
  • Latest: golfer
Stats
  • Total Posts: 55125
  • Total Topics: 4851
  • Online Today: 48
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 59
Total: 59

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: The TPP and END of U.S. Generic Access  (Read 7641 times)

0 Members and 1 Guest are viewing this topic.

Offline Coach Mike

  • Member
  • Posts: 292
    • Affordable Hepatitis C Treatment
Genotype 1a, Biopsy:11/2014: F-1, Tx Naive
Fibrosure, 7/20/15: F-1-2
Pre tx v/l: 1,600,000, ALT: 75, AST: 48
Started generic sofosbuvir & ledipasvir: 10/23/15
4 wk labs: 11/19/15, ALT: 21, AST: 16, V/L:  UND
Started 8 week Harvoni tx: 11/20/15
8 wk labs, 12/15/15, ALT: 15, AST: 13, V/L: UND
4/11/16 12 week EOT-Undetected
7/5/16 SVR 24

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: The TPP and END of U.S. Generic Access
« Reply #1 on: April 29, 2016, 09:11:58 pm »
Thanks Coach Mike, I'll do some reading on the TPP.  It just never ends, does it? FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline Coach Mike

  • Member
  • Posts: 292
    • Affordable Hepatitis C Treatment
Re: The TPP and END of U.S. Generic Access
« Reply #2 on: April 29, 2016, 09:18:13 pm »
Money. Follow the money.
I really had no clue until I researched the TPP. Gilead could theoretically sue the government for knowingly allowing generics that infringed on its patent to enter the country.
Sad. People are simply trying to heal themselves.
What have we become?
cm
Genotype 1a, Biopsy:11/2014: F-1, Tx Naive
Fibrosure, 7/20/15: F-1-2
Pre tx v/l: 1,600,000, ALT: 75, AST: 48
Started generic sofosbuvir & ledipasvir: 10/23/15
4 wk labs: 11/19/15, ALT: 21, AST: 16, V/L:  UND
Started 8 week Harvoni tx: 11/20/15
8 wk labs, 12/15/15, ALT: 15, AST: 13, V/L: UND
4/11/16 12 week EOT-Undetected
7/5/16 SVR 24

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: The TPP and END of U.S. Generic Access
« Reply #3 on: May 02, 2016, 01:53:56 pm »
Hey Coach Mike, I read several articles yesterday on the TPP deal.  It's a lengthy document that sounds like will affect some aspect, if not many, in most of our lives, so we do need to learn more about it. I have to admit it's a topic I've not paid a great deal of attention to in the past......

We are currently in the ratifying stage of this process, which is to take 2 years, so that is the next topic I'll search. Thanks, FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

Offline KimInTheForest

  • Member
  • Posts: 1,972
  • Believe in yourself
Re: The TPP and END of U.S. Generic Access
« Reply #4 on: May 02, 2016, 05:18:14 pm »
This is a big issue in Canada as well (the TPP curtailing access to generic drugs) and has been reported in major Canadian news media:

http://www.theglobeandmail.com/report-on-business/drug-prices-expected-to-rise-as-result-of-trade-deal/article27627091/

kim
Kim Goldberg (Nanaimo, BC)
1970s: Contracted HCV (genotype 3a)
2015: Cured with Harvoni + ribavirin (12 weeks)
MY STORY: https://pigsquash.wordpress.com/2016/01/28/undetectable-my-hep-c-story/

Offline Coach Mike

  • Member
  • Posts: 292
    • Affordable Hepatitis C Treatment
Re: The TPP and END of U.S. Generic Access
« Reply #5 on: May 02, 2016, 05:34:25 pm »
Yes FT & Kim,
This thing, as one aspiring politician would say, is "HUGE", even IF his hands are a bit on the smallish side...
It's hard to say, given our current political state, when, if ever, this thing might get approved.
I don't like big, complicated acts that I can't fully understand.
This qualifies.
cm
Genotype 1a, Biopsy:11/2014: F-1, Tx Naive
Fibrosure, 7/20/15: F-1-2
Pre tx v/l: 1,600,000, ALT: 75, AST: 48
Started generic sofosbuvir & ledipasvir: 10/23/15
4 wk labs: 11/19/15, ALT: 21, AST: 16, V/L:  UND
Started 8 week Harvoni tx: 11/20/15
8 wk labs, 12/15/15, ALT: 15, AST: 13, V/L: UND
4/11/16 12 week EOT-Undetected
7/5/16 SVR 24

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: The TPP and END of U.S. Generic Access
« Reply #6 on: May 02, 2016, 06:04:44 pm »
Yes, this document is very complex and long, but I see re: ratification that it looks like we have some time to contact our respective senators and reps and give our opinion. Japan and the US are the largest countries involved out of the 12 and carry a lot of weight in this process.  Japan has started their process; due to our election, most say our congress won't be looking at this seriously until after the election. So we have some time to devise our statements and get them in. Six of the 12 countries must ratify, so who knows how that will go, as protests have & are being held in various countries in opposition.

While I appreciate the skepticism that our voices don't seem to be heard much, we have the right to express our opinions, and should. Perhaps we can use this as a "teachable moment" re: the trials and frustration for so many with obtaining HCV treatment. Another form of education.

In addition to the most important aspect of potentially limiting lifesaving drugs to patients around the world, another aspect is our continued high cost of healthcare in the US.  If generics were to be limited as a viable option, that will only add to costs. I personally don't think our current healthcare system could handle this.

Thanks for bringing this important topic up for all of us. Money is the real "American Idol" if you ask me............ FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.